Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19

被引：18
作者：
Chistolini, Antonio [1 ]
Ruberto, Franco [2 ]
Alessandri, Francesco [2 ]
Santoro, Cristina [1 ]
Barone, Francesco [1 ]
Cristina Puzzolo, Maria [1 ]
Ceccarelli, Giancarlo [3 ]
De Luca, Maria L. [1 ]
Mancone, Massimo [4 ]
Alvaro, Domenico [5 ]
Pulcinelli, Fabio M. [6 ]
Martelli, Maurizio [1 ]
Foa, Robin [1 ]
Pugliese, Francesco [2 ]
机构：
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Hematol, Rome, Italy
[2] Sapienza Univ Rome, Dept Gen Surg Surg Specialties & Organ Transplant, Rome, Italy
[3] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy
[4] Sapienza Univ Rome, Dept Clin Internal Med Anesthesiol & Cardiovasc S, Rome, Italy
[5] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
[6] Sapienza Univ Rome, Dept Expt Med, Rome, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 190卷 / 04期
关键词：
COVID-19; thrombin generation assay; low-molecular-weight heparin;
D O I：
10.1111/bjh.17003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E214 / E218
页数：5
相关论文
共 50 条
  • [21] Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
    Massimo Mattioli
    Devis Benfaremo
    Mauro Mancini
    Luciano Mucci
    Paola Mainquà
    Antonio Polenta
    Patrizia Maria Baldini
    Francesca Fulgenzi
    Donatella Dennetta
    Samuele Bedetta
    Lorenzo Gasperoni
    Alessandro Caraffa
    Gabriele Frausini
    Journal of Thrombosis and Thrombolysis, 2021, 51 : 286 - 292
  • [22] Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
    Mattioli, Massimo
    Benfaremo, Devis
    Mancini, Mauro
    Mucci, Luciano
    Mainqua, Paola
    Polenta, Antonio
    Baldini, Patrizia Maria
    Fulgenzi, Francesca
    Dennetta, Donatella
    Bedetta, Samuele
    Gasperoni, Lorenzo
    Caraffa, Alessandro
    Frausini, Gabriele
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (02) : 286 - 292
  • [23] The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients
    Reichman-Warmusz, Edyta
    Warmusz, Oliwia
    Wojnicz, Romuald
    OPEN MEDICINE, 2022, 17 (01): : 216 - 220
  • [24] Higher Doses of Low-Molecular-Weight Heparin (Enoxaparin) Are Needed to Achieve Target Anti-Xa Concentrations in Critically Ill Children
    Schloemer, Nathan J.
    Abu-Sultaneh, Samer
    Hanson, Sheila J.
    Yan, Ke
    Hoffmann, Raymond G.
    Punzalan, Rowena C.
    Havens, Peter L.
    PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (07) : E294 - E299
  • [25] The efficacy of low molecular weight heparin is reduced in COVID-19
    Watson, Oliver
    Zaldua, Jun-Cezar
    Pillai, Suresh
    Whitley, Janet
    Howard, Matthew
    Lawrence, Matthew
    Hawkins, Karl
    Morris, Keith
    Evans, Phillip Adrian
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2023, 84 (03) : 333 - 344
  • [26] Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery
    De, Anushtup
    Roy, Prabal
    Garg, Vinod K.
    Pandey, Narendra K.
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (01) : 57 - 61
  • [27] Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study
    Aschieri, Daniela
    Stabile, Marco
    Maestri, Cristina
    Rosato, Luca
    Coccia, Michela Giovanna
    Novara, Paola
    Lanati, Gianluca
    Di Dio, Maria Teresa
    Franco, Cosimo
    Bisceglie, Giuseppina
    Leddi, Giuseppe
    Fabrizi, Enrico
    Rucci, Paola
    Taliani, Gloria
    EMERGENCY CARE JOURNAL, 2021, 17 (03)
  • [28] Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients
    Fragkou, Paraskevi C.
    Palaiodimou, Lina
    Stefanou, Maria Ioanna
    Katsanos, Aristeidis H.
    Lambadiari, Vaia
    Paraskevis, Dimitrios
    Andreadou, Elisabeth
    Dimopoulou, Dimitra
    Zompola, Christina
    Ferentinos, Panagiotis
    Vassilakopoulos, Theodoros, I
    Kotanidou, Anastasia
    Sfikakis, Petros P.
    Tsiodras, Sotirios
    Tsivgoulis, Georgios
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2022, 15
  • [29] Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation
    Elvira Grandone
    Giovanni Tiscia
    Raffaele Pesavento
    Antonio De Laurenzo
    Davide Ceccato
    Maria Teresa Sartori
    Lucia Mirabella
    Gilda Cinnella
    Mario Mastroianno
    Lidia Dalfino
    Donatella Colaizzo
    Roberto Vettor
    Mariano Intrieri
    Angelo Ostuni
    Maurizio Margaglione
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 772 - 778
  • [30] Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation
    Grandone, Elvira
    Tiscia, Giovanni
    Pesavento, Raffaele
    De Laurenzo, Antonio
    Ceccato, Davide
    Sartori, Maria Teresa
    Mirabella, Lucia
    Cinnella, Gilda
    Mastroianno, Mario
    Dalfino, Lidia
    Colaizzo, Donatella
    Vettor, Roberto
    Intrieri, Mariano
    Ostuni, Angelo
    Margaglione, Maurizio
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 772 - 778
12345